List of Excipients in API sitagliptin
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing sitagliptin
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Merck Sharp & Dohme LLC | JANUVIA | sitagliptin | 0006-0221 | ANHYDROUS DIBASIC CALCIUM PHOSPHATE | 2027-05-24 |
| Merck Sharp & Dohme LLC | JANUVIA | sitagliptin | 0006-0221 | CELLULOSE, MICROCRYSTALLINE | 2027-05-24 |
| Merck Sharp & Dohme LLC | JANUVIA | sitagliptin | 0006-0221 | CROSCARMELLOSE SODIUM | 2027-05-24 |
| Merck Sharp & Dohme LLC | JANUVIA | sitagliptin | 0006-0221 | FERRIC OXIDE RED | 2027-05-24 |
| Merck Sharp & Dohme LLC | JANUVIA | sitagliptin | 0006-0221 | FERRIC OXIDE YELLOW | 2027-05-24 |
| Merck Sharp & Dohme LLC | JANUVIA | sitagliptin | 0006-0221 | MAGNESIUM STEARATE | 2027-05-24 |
| Merck Sharp & Dohme LLC | JANUVIA | sitagliptin | 0006-0221 | POLYETHYLENE GLYCOL | 2027-05-24 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for sitagliptin
Excipient focus: ALUMINUM OXIDE
sitagliptin drug variants containing ALUMINUM OXIDE
sitagliptin drug variants not containing ALUMINUM OXIDE
Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE
sitagliptin drug variants containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
sitagliptin drug variants not containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
Excipient focus: CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
sitagliptin drug variants containing CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Clinical Solutions Wholesale | sitagliptin | 58118-0277 |
| >Company | >Ingredient | >NDC |
sitagliptin drug variants not containing CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
Excipient focus: CARNAUBA WAX
sitagliptin drug variants containing CARNAUBA WAX
sitagliptin drug variants not containing CARNAUBA WAX
Excipient focus: CELLULOSE, MICROCRYSTALLINE
sitagliptin drug variants containing CELLULOSE, MICROCRYSTALLINE
sitagliptin drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | sitagliptin and metformin hydrochloride | 50090-4411 |
| A-S Medication Solutions | sitagliptin and metformin hydrochloride | 50090-5504 |
| A-S Medication Solutions | sitagliptin and metformin hydrochloride | 50090-6244 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
sitagliptin drug variants containing CROSCARMELLOSE SODIUM
sitagliptin drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: FD&C BLUE NO. 2
sitagliptin drug variants containing FD&C BLUE NO. 2
sitagliptin drug variants not containing FD&C BLUE NO. 2
Excipient focus: FERRIC OXIDE RED
sitagliptin drug variants containing FERRIC OXIDE RED
sitagliptin drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
sitagliptin drug variants containing FERRIC OXIDE YELLOW
sitagliptin drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: FERROSOFERRIC OXIDE
sitagliptin drug variants containing FERROSOFERRIC OXIDE
sitagliptin drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: HYDROXYPROPYL CELLULOSE
sitagliptin drug variants containing HYDROXYPROPYL CELLULOSE
sitagliptin drug variants not containing HYDROXYPROPYL CELLULOSE
Excipient focus: HYPROMELLOSE 2208
sitagliptin drug variants containing HYPROMELLOSE 2208
sitagliptin drug variants not containing HYPROMELLOSE 2208
Excipient focus: HYPROMELLOSE 2910
sitagliptin drug variants containing HYPROMELLOSE 2910
sitagliptin drug variants not containing HYPROMELLOSE 2910
Excipient focus: INDIGOTINDISULFONATE SODIUM
sitagliptin drug variants containing INDIGOTINDISULFONATE SODIUM
sitagliptin drug variants not containing INDIGOTINDISULFONATE SODIUM
Excipient focus: KAOLIN
sitagliptin drug variants containing KAOLIN
sitagliptin drug variants not containing KAOLIN
Excipient focus: LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
sitagliptin drug variants containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals (USA) Inc | sitagliptin and metformin hydrochloride | 70710-1786 |
| Zydus Lifesciences Limited | sitagliptin and metformin hydrochloride | 70771-1859 |
| >Company | >Ingredient | >NDC |
sitagliptin drug variants not containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
Excipient focus: MAGNESIUM STEARATE
sitagliptin drug variants containing MAGNESIUM STEARATE
sitagliptin drug variants not containing MAGNESIUM STEARATE
Excipient focus: MALIC ACID
sitagliptin drug variants containing MALIC ACID
sitagliptin drug variants not containing MALIC ACID
Excipient focus: POLYETHYLENE GLYCOL
sitagliptin drug variants containing POLYETHYLENE GLYCOL
sitagliptin drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 3350
sitagliptin drug variants containing POLYETHYLENE GLYCOL 3350
sitagliptin drug variants not containing POLYETHYLENE GLYCOL 3350
Excipient focus: POLYETHYLENE GLYCOLS
sitagliptin drug variants containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| Clinical Solutions Wholesale | sitagliptin | 58118-0277 |
| >Company | >Ingredient | >NDC |
sitagliptin drug variants not containing POLYETHYLENE GLYCOLS
Excipient focus: POLYVINYL ALCOHOL
sitagliptin drug variants containing POLYVINYL ALCOHOL
sitagliptin drug variants not containing POLYVINYL ALCOHOL
Excipient focus: POVIDONE
sitagliptin drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals (USA) Inc | sitagliptin | 70710-1240 |
| Zydus Pharmaceuticals (USA) Inc | sitagliptin | 70710-1899 |
| Zydus Lifesciences Limited | sitagliptin | 70771-1770 |
| Zydus Lifesciences Limited | sitagliptin | 70771-1790 |
| >Company | >Ingredient | >NDC |
sitagliptin drug variants not containing POVIDONE
Excipient focus: POVIDONE K30
sitagliptin drug variants containing POVIDONE K30
sitagliptin drug variants not containing POVIDONE K30
Excipient focus: PROPYL GALLATE
sitagliptin drug variants containing PROPYL GALLATE
sitagliptin drug variants not containing PROPYL GALLATE
Excipient focus: SILICON DIOXIDE
sitagliptin drug variants containing SILICON DIOXIDE
sitagliptin drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM LAURYL SULFATE
sitagliptin drug variants containing SODIUM LAURYL SULFATE
sitagliptin drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: SODIUM STEARYL FUMARATE
sitagliptin drug variants containing SODIUM STEARYL FUMARATE
sitagliptin drug variants not containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals (USA) Inc | sitagliptin | 70710-1240 |
| Zydus Pharmaceuticals (USA) Inc | sitagliptin | 70710-1899 |
| Zydus Lifesciences Limited | sitagliptin | 70771-1770 |
| Zydus Lifesciences Limited | sitagliptin | 70771-1790 |
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
sitagliptin drug variants containing TALC
sitagliptin drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
sitagliptin drug variants containing TITANIUM DIOXIDE
sitagliptin drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
